Allogene Therapeutics Funding & Investors
Allogene Therapeutics, Inc. operates as a biotechnology company. The Company develops allogeneic chimeric antigen receptor T-cell therapy for the treatment of blood cancers and solid tumors. Allogene Therapeutics serves patients in the State of California.
allogene.comTotal Amount Raised: $531,770,400
Allogene Therapeutics Funding Rounds
Convertible Note
$120,000,000
Convertible Note Investors
Perceptive AdvisorsDeerfield Capital ManagementFidelity InvestmentsJennison AssociatesFranklin ResourcesT. Rowe PriceSurveyor CapitalvenBio Select AdvisorCowen Investment ManagementSeries A
$411,770,409
Series A Investors
TPGVida VenturesPfizerTwo RiverBellco CapitalGilead Sciences
Funding info provided by Diffbot.